Form4insider filings, from the source

SEC Form 4 · accession 0001182489-15-000697

Nexvet Biopharma plc · NVET

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
FARALLON PARTNERS L L C/CA
10% Owner · Other
Monica R Landry
10% Owner · Other
Richard B Fried
10% Owner · Other
Andrew J M Spokes
10% Owner · Other
Thomas G. Roberts Jr.
10% Owner · Other
Daniel J. Hirsch
10% Owner · Other
Michael G Linn
10% Owner · Other
David T Kim
10% Owner · Other
Michael B. Fisch
10% Owner · Other
Period of report
Sep 9, 2015
Accepted (ET)
Sep 11, 2015 · 4:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618561

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Ordinary SharesF1,F2,F3Sep 9, 2015P31$5.75A787,066D
Ordinary SharesF1,F2,F3Sep 10, 2015P1,133$6.48A788,199D
Ordinary SharesF1,F2,F4Sep 9, 2015P34$5.75A848,817D
Ordinary SharesF1,F2,F4Sep 10, 2015P1,222$6.48A850,039D
Ordinary SharesF1,F2,F5Sep 9, 2015P35$5.75A864,213D
Ordinary SharesF1,F2,F5Sep 10, 2015P1,245$6.48A865,458D
Ordinary SharesF1,F2,F3,F7,F8Sep 9, 2015P5$5.75A115,161ISee Footnotes
Ordinary SharesF1,F2,F3,F7,F8Sep 10, 2015P166$6.48A115,327ISee Footnotes
Ordinary SharesF1,F2,F4,F9Sep 9, 2015P9$5.75A235,467ISee Footnotes
Ordinary SharesF1,F2,F4,F9Sep 10, 2015P339$6.48A235,806ISee Footnotes
Ordinary SharesF1,F2,F5,F10Sep 9, 2015P8$5.75A197,819ISee Footnotes
Ordinary SharesF1,F2,F5,F10Sep 10, 2015P285$6.48A198,104ISee Footnotes
Ordinary SharesF1,F2,F11Sep 9, 2015P78$5.75A1,951,649ISee Footnotes
Ordinary SharesF1,F2,F11Sep 10, 2015P2,810$6.48A1,954,459ISee Footnotes
Ordinary SharesF1,F2,F6,F12,F13Sep 9, 2015P100$5.75A2,500,096ISee Footnotes
Ordinary SharesF1,F2,F6,F12,F13Sep 10, 2015P3,600$6.48A2,503,696ISee Footnotes

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses